Sentien Biotechnologies, Inc.
CAGE Code: 59MH0
NCAGE Code: 59MH0
Status: Active
Type: Commercial Supplier
Dun & Bradstreet (DUNS): 828970900
Summary
Sentien Biotechnologies, Inc. is an Active Commercial Supplier with the Cage Code 59MH0 and is tracked by Dun & Bradstreet under DUNS Number 828970900..
Address
99 Hayden Ave Ste 140
Lexington MA 02421-7998
United States
Points of Contact
No Points of Contact...
Related Information
People who viewed this 'CAGE Code' also viewed...
Univeristy Of Kentucky Allied Health Agilent Technologies, Inc. Cajun Kitchen Usa Food Services Kyzer Building Services /K B S/ Willcutt Guitar Shoppe Inc Compost Casa Guardian Pros Llc Phishingbox, Llc Wilson Farms Inc Atria Software Smith Management Group, Inc. Master Technologies Repair Corp Kentucky Statewide Independent Proseeding & Environmental Services, Printer Pro Cartridge Recycling And Riley And Ryan P C Lexmark International, Inc. Dillon Supply Co Traveling Dentist Llc Government Sales Co
Frequently Asked Questions (FAQ) for CAGE 59MH0
- What is CAGE Code 59MH0?
- 59MH0 is the unique identifier used by NATO Organizations to reference the physical entity known as Sentien Biotechnologies, Inc. located at 99 Hayden Ave Ste 140, Lexington MA 02421-7998, United States.
- Who is CAGE Code 59MH0?
- 59MH0 refers to Sentien Biotechnologies, Inc. located at 99 Hayden Ave Ste 140, Lexington MA 02421-7998, United States.
- Where is CAGE Code 59MH0 Located?
- CAGE Code 59MH0 is located in Lexington, MA, USA.
Contracting History for CAGE 59MH0 Most Recent 25 Records
- 75A50121C00072
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 25 Jan 2023
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00072
- E014042 Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 24 Feb 2022
- E014042 Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00072
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 8 Dec 2022
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00072
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 27 Feb 2023
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $510,265.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00072
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 24 Jun 2022
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $749,999.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00072
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 13 Aug 2021
- Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $510,265.00
- Department Of Health And Human Services (Hhs)
- 75A50121C00072
- E014042 Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- 1 Nov 2021
- E014042 Sentien Biotechnologies, Inc.: R&D Of Ex Vivo Cell Therapy
- Barda - Aspr / Daappo / Barda Dcma
- Department Of Health And Human Services (Hhs)
- $686,622.00
- Department Of Health And Human Services (Hhs)